Clinical trials recruiting in Gonesse, France

Phase breakdown

Conditions recruiting in Gonesse, France

Recruiting trials in Gonesse, France

• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
  NCT07225504 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• French Registry for Monitoring Pregnancies for Multiple Sclerosis
  NCT03900221 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial
  NCT05999604 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
  NCT05758831 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Gonesse, France?

4 recruiting trials have at least one study site in Gonesse, France.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.